This series on “Innovations in the Diagnosis and Management of Uveitis” is edited by Steven Yeh, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA; Emory Eye Center, Emory University School of Medicine, Atlanta, GA, USA.
We hope this special edition of Annals of Eye Science will provide the reader with broad insight on the “State-of-the-art” in uveitis and future directions to care for this complex array of ocular inflammatory diseases.
Innovations in the diagnosis and management of uveitis: promising research to address unmet patient needs
Update on the diagnosis and treatment of Vogt-Koyanagi-Harada syndrome
Uveitis secondary to cancer therapeutics
Pediatric uveitis: EYE-Q and metrics beyond visual acuity
Diagnosis and treatment of autoimmune retinopathy
Altering the intestinal microbiota for therapeutic benefit in uveitis
Novel diagnostic imaging techniques and applications in anterior uveitis, intermediate uveitis, and scleritis
Biologics in non-infectious uveitis past, present and future
Advances in the diagnosis and management of acute retinal necrosis
Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis
Cytomegalovirus retinitis in the highly active anti-retroviral therapy era
To be updated
Disclosure:
The series “Innovations in the Diagnosis and Management of Uveitis” was commissioned by the editorial office, Annals of Eye Science without any sponsorship or funding. Steven Yeh served as the unpaid Guest Editor for the series.